Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada

PLoS Medicine

Volumn 7, Issue 4, 2010, Pages

  Skowronski, Danuta M ^a   de Serres, Gaston ^b   Crowcroft, Natasha S ^c,d   Janjua, Naveed Z ^a   Boulianne, Nicole ^b   Hottes, Travis S ^a   Rosella, Laura C ^c,d   Dickinson, James A ^e   Gilca, Rodica ^b   Sethi, Pam ^c   Ouhoummane, Najwa ^b   Willison, Donald J ^c   Rouleau, Isabelle ^b   Petric, Martin ^a   Fonseca, Kevin ^f   Drews, Steven J ^e   Rebbapragada, Anuradha ^c   Charest, Subhugues ^b   Hamelin, Marie Ève ^g   Boivin, Guy ^g   Gardy, Jennifer L ^a   Li, Yan ^h   Kwindt, Trijntje L ^a   Patrick, David M ^a   Brunham, Robert C ^a   more..

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f Alberta Provincial Laboratory   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PANDEMIC INFLUENZA; POPULATION BASED CASE CONTROL STUDY; SEASONAL INFLUENZA; SPRING; SUMMER; VIRUS TRANSMISSION; EPIDEMIC; INFLUENZA; INFLUENZA VIRUS A H1N1; OBSERVATION; PATHOGENICITY; VIROLOGY;

CANADA; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; OBSERVATION;

EID: 77951745708     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000258     Document Type: Article

References (51)

1. CDC (2009) Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 58: 400-402.
2. Novel swine-origin influenza A(H1N1) virus investigation team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New Engl J Med 361: 1-10.
3. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. New Engl J Med 361: 674-79.
4. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swineorigin influenza A (H1N1) in Mexico. New Engl J Med 361: 680-89.
5. WHO (11 June 2009) Transcript of statement by Margaret Chan, Director-General of the World Health Organization. Available: http://www.who.int/mediacentre/influenzaAH1N1_presstranscript_20090611.pdf. Accessed 26 February 2010.
6. Katz J, Hancock K, Veguilla V, Zhong W, Sun H, et al. (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58: 521-524.
7. WHO (2009) WHO pandemic (H1N1) briefing note 9: Preparing for the second wave: lessons from current outbreaks. Available at: http://www.who.int/csr/disease/swineflu/notes/h1n1_second_wave_20090828/en/index.html. Accessed 26 February 2010.
8. National Advisory Committee on Immunization (2008) Statement on influenza vaccination for the 2008-09 season. Can Commun Dis Rep ACS-3 34: 1-46.
9. Janjua NZ, Skowronski DM, Hottes TS, Osei W, Petric M, et al. (2010) Seasonal influenza vaccine and increased risk of pandemic H1N1 illness: first detection of the association during outbreak investigation in British Columbia, Canada. 13th Annual Conference on Vaccine Research, Bethesda, MD, 27 April 2010. Abstract # 130.
10. Skowronski DM, Gilbert M, Tweed SA, Petric M, Li Y, et al. (2005) Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-05. Can Commun Dis Rep 31: 181-192.
11. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, et al. (2007) Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25: 2842-2851.
12. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, et al. (2009) Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-07. J Infect Dis 199: 168-179.
13. Rodrigues L, Kirkwood BR (1990) Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 19: 205-13.
14. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, et al. (1985) Field evaluation of vaccine efficacy. Bull WHO 63: 1055-1068.
15. Statistics Canada (2005) Canadian Community Health Survey (Cycle 3.1). Ottawa, ON.
16. Statistics Canada (2009) Influenza Immunization Coverage by Province and age 2007-08. In: Table 105-0502. Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2007 boundaries) and peer groups, occasional (1209600 series). Available: http://cansim2.statcan.gc.ca/cgiwin/cnsmcgi.pgm?Lang=E&RootDir=CII/&Array_Pick=1&ArrayId=105-0502&C2DB=PRD&ResultTemplate=CII%2FCII.
17. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
18. Hancock K, Veguilla V, Xiuhua L, Zhong W, Butler EN, et al. (2009) Crossreactive antibody responses to the 2009 pandemic H1N1 influenza virus. 361: 1-8.
19. Hak E, Verheij ThJM, Grobbee DE, Nichol KL, et al. (2002) Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 56: 951-955.
20. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35: 337-344.
21. Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, et al. (2006) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35: 345-352.
22. Kelly H, Grant K (2009) Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Eurosurveillance 14. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19288. Accessed 26 February 2010.
23. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, et al. (2009) Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: casecontrol study in Mexico City. BMJ 339: b3928. Available: http://www.bmj.com/cgi/content/full/339/oct06_2/b3928 Accessed 26 February 2010.
24. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, et al. (2009) Infection and deaths from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 374: 2072-2079.
25. Gargiullo P, Shay D, Katz J, Bramley A, Nowell M, et al. (2009) Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) -United States, May-June 2009. MMWR Morb Mortal Wkly Rep 58: 1241-1245.
26. Iuliano AD, Reed C, Guh A, Desai M, Kutty P, et al. (2009) Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis 49: 1811-1820.
27. Crum-Cianflone NF, Blair PJ, Faix D, Arnold J, Echols S, et al. (2009) Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 49: 1801-1810.
28. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, Crowcroft NS, et al. (2009) Seasonal vaccine and H1N1. Selection bias explains seasonal vaccine's protection. BMJ 339: b4972.
29. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, Crowcroft NS, et al. (2010) Bias and seasonal vaccine effectiveness against pandemic A/H1N1. Lancet 375: 801-802.
30. Hoskins TW, Davies JR, Smith AJ, Alchin A, Miller CL, et al. (1976) Influenza at Christ's Hospital: March, 1974. Lancet 1: 105-108.
31. Bodewes R, Kreijtz JHCM, Baas C, Geelhoed-Mieras MM, de Mutsert G, et al. (2009) Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 Virus. PLoS ONE 4: e5538. doi:10.1371/journal.pone.0005538.
32. Bodewes R, Kreijtz JHCM, Rimmelzwaan GF (2009) Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis 9: 784-788.
33. Palese P (2004) Influenza: new and old threats. Nat Med 10: S82-7.
34. Webster RG (1966) Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 97: 177-183.
35. Fazekas G, Webster RG (1966) Disquisitions on original antigenic sin, II: proof in lower creatures. J Exp Med 124: 347-361.
36. Fazekas G, Webster RG (1966) Disquisitions of original antigenic sin, I: evidence in man. J Exp Med 124: 331-345.
37. Kim JH, Skountzou I, Compans R, Jacob J (2009) Original antigenic sin responses to influenza viruses. J Immunol 183: 3294-3301.
38. Stephenson JR (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull WHO 83: 308-314.
39. Sauter P, Hober D (2009) Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect 11: 443-451.
40. Takada A, Kawaoka Y (2003) Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13: 387-398.
41. Gotoff R, Tamura M, Janus J, Thompson J, Wright P, et al. (1994) Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells. J Infect Dis 169: 200-203.
42. Ochiai H, Kurokawa M, Kuroki Y, Niwayama S (1990) Infection enhancement of influenza A H1 subtype viruses in macrophage-like P388D1 cells by cross- reactive antibodies. J Med Virol 30: 258-265.
43. Ochiai H, Kurokawa M, Hayashi K, Niwayama S (1988) Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol 62: 20-26.
44. Ochiai H, Kurokawa M, Matsui S, Yamamoto T, Kuroki Y, et al. (1992) Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody. J Med Virol 36: 217-221.
45. Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA (2008) Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 126: 310-323.
46. Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, et al. (2006) The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet Immunol Immunopathol 112: 117-128.
47. Kobinger GP, Meunier I, Patel A, Pillet S, Green J, et al. (2010) Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis 201: 1000-1006.
48. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Preexisting immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370. Available: http://www.pnas.org/content/106/48/20365. Accessed 26 February 2010.
49. World Health Organization (2010) Pandemic (H1N1) 2009 update 89. Weekly virological surveillance update. Available at: http://www.who.int/csr/disease/swineflu/laboratory26_02_2010/en/index.html. Accessed 26 February 2010.
50. World Health Organization (2010) Recommended composition of influenza vaccines for use in the 2010 southern hemisphere influenza season. Available at: http://www.who.int/csr/disease/influenza/recommendations2010south/en/index.html. Accessed 26 February 2010.
51. World Health Organization (2010) Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Available at: http://www.who.int/csr/disease/influenza/recommendations2010_11north/en/index.html. Accessed 26 February 2010.